BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25616133)

  • 1. c-MYB regulates cell growth and DNA damage repair through modulating MiR-143.
    Wang W; Wu S; Shi Y; Miao Y; Luo X; Ji M; Yao K; He J
    FEBS Lett; 2015 Feb; 589(5):555-64. PubMed ID: 25616133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.
    Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y
    Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.
    Wang WJ; Wu SP; Liu JB; Shi YS; Huang X; Zhang QB; Yao KT
    Cancer Res; 2013 Feb; 73(3):1219-31. PubMed ID: 23269272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
    Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
    Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S; Li X; Zhu H
    Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease.
    Zhu ZR; He Q; Wu WB; Chang GQ; Yao C; Zhao Y; Wang M; Wang SM
    J Atheroscler Thromb; 2018 Nov; 25(11):1168-1181. PubMed ID: 29760303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
    D'Aguanno S; Valentini E; Tupone MG; Desideri M; Di Martile M; Spagnuolo M; Buglioni S; Ercolani C; Falcone I; De Dominici M; Milella M; Rizzo MG; Calabretta B; Cota C; Anichini A; Trisciuoglio D; Del Bufalo D
    J Exp Clin Cancer Res; 2018 Nov; 37(1):278. PubMed ID: 30454024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathway.
    Zheng Z; Qu JQ; Yi HM; Ye X; Huang W; Xiao T; Li JY; Wang YY; Feng J; Zhu JF; Lu SS; Yi H; Xiao ZQ
    Cell Death Dis; 2017 Jun; 8(6):e2855. PubMed ID: 28569771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
    Liu Y; Zhao R; Wang H; Luo Y; Wang X; Niu W; Zhou Y; Wen Q; Fan S; Li X; Xiong W; Ma J; Li X; Tan M; Li G; Zhou M
    Cell Death Dis; 2016 Mar; 7(3):e2156. PubMed ID: 27010857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R.
    Farhana L; Dawson MI; Murshed F; Das JK; Rishi AK; Fontana JA
    PLoS One; 2013; 8(5):e61015. PubMed ID: 23675407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myb regulates transcriptional activation of miR-143/145 in vascular smooth muscle cells.
    Chandy M; Ishida M; Shikatani EA; El-Mounayri O; Park LC; Afroze T; Wang T; Marsden PA; Husain M
    PLoS One; 2018; 13(8):e0202778. PubMed ID: 30169548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma.
    Deng M; Tang H; Zhou Y; Zhou M; Xiong W; Zheng Y; Ye Q; Zeng X; Liao Q; Guo X; Li X; Ma J; Li G
    J Cell Sci; 2011 Sep; 124(Pt 17):2997-3005. PubMed ID: 21878506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells.
    Zhao H; Kalota A; Jin S; Gewirtz AM
    Blood; 2009 Jan; 113(3):505-16. PubMed ID: 18818396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
    Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
    J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.
    Yan HL; Li L; Li SJ; Zhang HS; Xu W
    J Biochem Mol Toxicol; 2016 Dec; 30(12):602-607. PubMed ID: 27501413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.